세계의 미용 의료 시장 : 제품 유형별, 성별, 최종 사용자별 - 예측(2025-2030년)

The Aesthetic Medicine Market was valued at USD 81.81 billion in 2023, expected to reach USD 91.59 billion in 2024, and is projected to grow at a CAGR of 12.33%, to USD 184.65 billion by 2030.

Aesthetic medicine, a rapidly evolving field encompassing non-invasive and minimally invasive procedures to enhance cosmetic appearance, is driven by the increasing desire for beauty and self-confidence among consumers. This sector includes treatments like botulinum toxin injections, dermal fillers, chemical peels, laser hair removal, and body contouring. The necessity for aesthetic medicine is underscored by a growing aging population and increasing disposable incomes, which amplify demand for maintaining youthful appearances. The applications span dermatology clinics, medical spas, and beauty centers, serving both male and female clients seeking treatments for anti-aging, skin resurfacing, and rejuvenation. Market growth is significantly influenced by technological advancements in laser, light, and energy-based therapies, alongside a broader acceptance of aesthetic procedures. Key opportunities lie in expanding markets in Asia-Pacific and Latin America, where growing urbanization and changing beauty standards fuel demand. Additionally, increasing social media influence and the rise of medical tourism provide further potential growth avenues. Nevertheless, market expansion faces limitations from stringent regulatory approvals, the high cost of procedures, and the potential for adverse effects, which can deter consumer interest. Innovation areas include developing safer, more effective, and longer-lasting treatment options, as well as personalized medicine approaches tailored to individual needs. Investing in virtual reality and artificial intelligence tools could enhance both practitioner proficiency and customer experience, fostering market differentiation. Companies should focus on expanding their presence in underpenetrated markets and fostering educational initiatives to mitigate misinformation and increase consumer awareness. Despite its challenges, the aesthetic medicine market offers substantial growth potential through innovation and strategic expansion into emerging economies, promising a dynamic future for businesses willing to navigate its complexities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Aesthetic Medicine Market

The Aesthetic Medicine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing preference for minimally invasive reconstruction surgeries
  • Proliferation in the number of congenital face disorders and breast deformities
  • Growing consumer awareness about aesthetic appearance globally
• Market Restraints
  • High cost of the aesthetic treatments
• Market Opportunities
  • Technological advancements in aesthetic surgical procedures
  • Introduction of advanced materials such as silicone implants in aesthetic surgery
• Market Challenges
  • Unfavorable reimbursement policies and stringent regulatory scenarios

Porter's Five Forces: A Strategic Tool for Navigating the Aesthetic Medicine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Aesthetic Medicine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Aesthetic Medicine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Aesthetic Medicine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Aesthetic Medicine Market

A detailed market share analysis in the Aesthetic Medicine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Aesthetic Medicine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Aesthetic Medicine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Aesthetic Medicine Market

A strategic analysis of the Aesthetic Medicine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Aesthetic Medicine Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Alma Lasers Ltd. by Shanghai Fosun Pharmaceutica Group Co., Ltd., Bioxis Pharmaceuticals, Black & Black Surgical, Inc., BTL Industries, Candela Corporation, Cutera, Inc., Cynosure Inc., Cytrellis, Inc., Dimeda Instrumente GmBH, Fotona d.o.o., Galderma SA, Inmode Ltd., Johnson & Johnson Services Inc., KARL STORZ SE & Co. KG, Lumenis Be Ltd. by Boston Scientific Corp., Lutronic Inc., Lynton Lasers Ltd., Medytox Inc., Merz Pharma GmbH & Co. KGaA, Millennium Surgical Corp., miraDry, Inc., Quanta System S.p.A. by El.En. S.p.A., Sciton, Inc., Sientra, Inc., Sinclair Pharma Ltd., Solta Medical, Strata Skin Sciences, Venus Concept, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Aesthetic Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Products, market is studied across Body Contouring Devices, Cosmetic Implants, Facial Aesthetic Products, Hair Removal Devices, Nail Treatment Laser Devices, Physician-Dispensed Eyelash Products, Skin Aesthetic Devices, Tattoo Removal Devices, and Thread Lift Products. The Body Contouring Devices is further studied across Cellulite Reduction Devices, Liposuction Devices, and Non-Surgical Fat Reduction Devices. The Cosmetic Implants is further studied across Breast implants, Facial implants, and Gluteal implants. The Facial Aesthetic Products is further studied across Botulinum toxin, Chemical peels, Derma Fillers, and Microdermabrasion products. The Skin Aesthetic Devices is further studied across Laser Skin Resurfacing Sevices, Light Therapy Devices, Microneedling Devices, and Non-surgical Skin Tightening Devices.
• Based on Type, market is studied across Invasive Procedures and Non-Invasive Procedures.
• Based on Gender, market is studied across Female and Male.
• Based on End-User, market is studied across Ambulatory Surgical Center, Beauty Center & Medical Spa, Dermatology Clinic, Home Setting, and Hospital.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing preference for minimally invasive reconstruction surgeries
    • 5.1.1.2. Proliferation in the number of congenital face disorders and breast deformities
    • 5.1.1.3. Growing consumer awareness about aesthetic appearance globally
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of the aesthetic treatments
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in aesthetic surgical procedures
    • 5.1.3.2. Introduction of advanced materials such as silicone implants in aesthetic surgery
  • 5.1.4. Challenges
    • 5.1.4.1. Unfavorable reimbursement policies and stringent regulatory scenarios
• 5.2. Market Segmentation Analysis
  • 5.2.1. Products: Rising demand for cosmetic implants to improve aesthetic appearances
  • 5.2.2. End-User: Increasing number of aesthetic surgeries conducted across dermatology clinics and cosmetic centers
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Aesthetic Medicine Market, by Products

• 6.1. Introduction
• 6.2. Body Contouring Devices
  • 6.2.1. Cellulite Reduction Devices
  • 6.2.2. Liposuction Devices
  • 6.2.3. Non-Surgical Fat Reduction Devices
• 6.3. Cosmetic Implants
  • 6.3.1. Breast implants
  • 6.3.2. Facial implants
  • 6.3.3. Gluteal implants
• 6.4. Facial Aesthetic Products
  • 6.4.1. Botulinum toxin
  • 6.4.2. Chemical peels
  • 6.4.3. Derma Fillers
  • 6.4.4. Microdermabrasion products
• 6.5. Hair Removal Devices
• 6.6. Nail Treatment Laser Devices
• 6.7. Physician-Dispensed Eyelash Products
• 6.8. Skin Aesthetic Devices
  • 6.8.1. Laser Skin Resurfacing Sevices
  • 6.8.2. Light Therapy Devices
  • 6.8.3. Microneedling Devices
  • 6.8.4. Non-surgical Skin Tightening Devices
• 6.9. Tattoo Removal Devices
• 6.10. Thread Lift Products

7. Aesthetic Medicine Market, by Type

• 7.1. Introduction
• 7.2. Invasive Procedures
• 7.3. Non-Invasive Procedures

8. Aesthetic Medicine Market, by Gender

• 8.1. Introduction
• 8.2. Female
• 8.3. Male

9. Aesthetic Medicine Market, by End-User

• 9.1. Introduction
• 9.2. Ambulatory Surgical Center
• 9.3. Beauty Center & Medical Spa
• 9.4. Dermatology Clinic
• 9.5. Home Setting
• 9.6. Hospital

10. Americas Aesthetic Medicine Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Aesthetic Medicine Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Aesthetic Medicine Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. MedShift Launches SaaS Platform for Medical Aesthetic Businesses
  • 13.3.2. ARCHIMED Buys WiQo, a Pioneer in the Field of Aesthetic Medicine
  • 13.3.3. Functionalab Completes Merger with FYi Medical Aesthetics, Creating the Largest Network of Premium Aesthetic Medicine Clinics in Canada
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. Alma Lasers Ltd. by Shanghai Fosun Pharmaceutica Group Co., Ltd.
• 3. Bioxis Pharmaceuticals
• 4. Black & Black Surgical, Inc.
• 5. BTL Industries
• 6. Candela Corporation
• 7. Cutera, Inc.
• 8. Cynosure Inc.
• 9. Cytrellis, Inc.
• 10. Dimeda Instrumente GmBH
• 11. Fotona d.o.o.
• 12. Galderma SA
• 13. Inmode Ltd.
• 14. Johnson & Johnson Services Inc.
• 15. KARL STORZ SE & Co. KG
• 16. Lumenis Be Ltd. by Boston Scientific Corp.
• 17. Lutronic Inc.
• 18. Lynton Lasers Ltd.
• 19. Medytox Inc.
• 20. Merz Pharma GmbH & Co. KGaA
• 21. Millennium Surgical Corp.
• 22. miraDry, Inc.
• 23. Quanta System S.p.A. by El.En. S.p.A.
• 24. Sciton, Inc.
• 25. Sientra, Inc.
• 26. Sinclair Pharma Ltd.
• 27. Solta Medical
• 28. Strata Skin Sciences
• 29. Venus Concept
• 30. Zimmer Biomet Holdings, Inc.